Parallel Stock
Consumer ProductsLooking to sell Parallel stock or options?
Parallel, a producer of medical products derived from cannabis, is devoted to enhancing health and well-being. It boasts an extensive array of exclusive brands that are provided in different formats including flower, pre-rolls, vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, soft gels and cannabis-infused products. These offerings are designed to aid consumers in enhancing their life quality through the advantages of cannabinoids.
Investors Include:
Poseidon Asset Management, Patrón Tequila, StartX (US), New World Health, G5 Capital (Greenwich), Wychwood Asset Management, Valkyrie Capital, LFG Ventures (VC).